Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Siege Of Mumbai Affects Workers At Two Japanese Pharmas In India

This article was originally published in PharmAsia News

Executive Summary

The terrorist siege of Mumbai, India, disrupted employee travel for several drug makers, including Daiichi Sankyo and Astellas Pharma. Both Japanese drug makers have subsidiaries based in India's financial capital. Daiichi ordered its employees on business trips to the area to return to Japan, while Astellas' few workers in a nascent marketing firm in the city were instructed to stay home. Several Daiichi personnel were in Mumbai to establish ties with Ranbaxy Laboratories, which Daiichi is converting into a subsidiary after buying the firm. (Click here for more - a subscription may be required

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067366

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel